Brzoska T, Luger TA, Maaser C, Abels C, Bohm M
BPC-157 is not supplied as a licensed medicinal product
National Library of Medicine (PubMed)
Toys [edit] In the European Union 1,2-cyclohexane dicarboxylic acid diisononyl ester was not listed in directive 2005/84/EC
Beginning at 0.25 mg daily allows you to assess your individual response before potentially increasing
Key reasons why BPC-157 is better than many traditional joint pain treatments: No known toxicity or side effects Accelerates healing in tendons, ligaments, muscles, and joints Non-invasive and drug-free Improves vascular repair and cellular regeneration Does not interfere with other medications or long-term health While painkillers and steroids may provide short-term relief, they do not promote tissue repair